Stevanato Group SPA (Stevanato Group SPA) Research & Development : $38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stevanato Group SPA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Stevanato Group SPA's Research & Development for the three months ended in Dec. 2023 was $11 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $38 Mil.

Stevanato Group SPA Research & Development Historical Data

The historical data trend for Stevanato Group SPA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SPA Research & Development Chart

Stevanato Group SPA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

8.70

21.16

33.46

36.43

38.90

Stevanato Group SPA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial												11.22	9.15	9.06	9.28	10.98

Stevanato Group SPA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $38 Mil.

Stevanato Group SPA (NYSE:STVN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Stevanato Group SPA Research & Development Related Terms

Thank you for viewing the detailed overview of Stevanato Group SPA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Stevanato Group SPA (Stevanato Group SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SPA (NYSE:STVN) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

87N:Germany

Address

Via Molinella 17, Piombino Dese, Padua, ITA, 35017

Website

https://www.stevanatogroup.com

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% from South America. It has two segments Biopharmaceutical and Diagnostic Solutions and Engineering.